Loading

Switching space...

Please wait while we prepare your workspace

Startup Image

DTECTIO

France, Villeparisis

Visit website

There is an increase prevalence of asymptomatic or intermittent heart diseases, like atrial fibrillation (17M people in Europe), Ischemic Stroke (0.9M in Europe) or Syncope (will affect 1/3 of people during their lifetime). Their detection requires continuous and long-term ECG monitoring. Implantable cardiac monitors are the “gold standard” to detect asymptomatic cardiac diseases. But they are invasive, selective & have a limited sequence recording time-frame. Alternatives (with patches or sensors) are uncomfortable, manual, or intermittent. Therefore, current solutions do not allow for non-invasive, continuous, and long-term monitoring, without disrupting patients' activities of daily living. DTECTIO provides long-term, non-invasive and context-aware continuous ECG recordings with vital signs, for patients with asymptomatic or intermittent heart diseases, without disrupting their activities of daily living.

FOUNDATION
YEAR
2020
EMPLOYEESN/A
AVERAGE AGEN/A